UPDATE 2-Bristol-Myers' cancer drug Opdivo fuels Wall Street beat

NEW YORK, April 27 (Reuters) - Strong growth from Bristol-Myers Squibb Co's Opdivo and Yervoy cancer immunotherapies drove the company's first-quarter results past analysts' expectations and relieved some anxiety about increasing competition for the drugs.

by reutersCOMPANYNEWS via Endless Supplies .Biz - News